198 related articles for article (PubMed ID: 22110217)
21. Predictors of quality of life after radical treatment for prostate cancer.
Gacci M; Lapini A; Serni S; Livi L; Paiar F; Detti B; Simontacchi G; Vittori G; Giubilei G; Mariani M; Palli D; Carini M
Urol Int; 2008; 80(3):231-6. PubMed ID: 18480622
[TBL] [Abstract][Full Text] [Related]
22. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
24. Comparison of quality of life following laparoscopic and open prostatectomy for prostate cancer.
Hara I; Kawabata G; Miyake H; Nakamura I; Hara S; Okada H; Kamidono S
J Urol; 2003 Jun; 169(6):2045-8. PubMed ID: 12771715
[TBL] [Abstract][Full Text] [Related]
25. Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy.
Davison BJ; Keyes M; Elliott S; Berkowitz J; Goldenberg SL
BJU Int; 2004 May; 93(7):965-9. PubMed ID: 15142144
[TBL] [Abstract][Full Text] [Related]
26. [Quality of life following radical prostatectomy].
Hodzic J; Jedrusik P; Reckwitz T; Golka K; Schulze H
Aktuelle Urol; 2003 Sep; 34(5):337-40. PubMed ID: 14566662
[TBL] [Abstract][Full Text] [Related]
27. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
[TBL] [Abstract][Full Text] [Related]
28. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
Allen GW; Howard AR; Jarrard DF; Ritter MA
Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384
[TBL] [Abstract][Full Text] [Related]
29. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
30. Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
[TBL] [Abstract][Full Text] [Related]
31. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
32. [Prostatectomy, brachytherapy, percutaneous irradiation. Which method helps your patients the most?].
Messer PM; Gottfried HW; Hautmann R; Röttinger EM
MMW Fortschr Med; 2002 Jan; 144(1-2):39-41. PubMed ID: 11847880
[TBL] [Abstract][Full Text] [Related]
33. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
Namiki S; Saito S; Tochigi T; Ioritani N; Terai A; Arai Y
Int J Urol; 2007 Mar; 14(3):186-91. PubMed ID: 17430252
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
Milecki P; Kwias Z; Martenka DJ
Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
[TBL] [Abstract][Full Text] [Related]
35. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of quality of life of patients receiving treatment for prostate cancer.
Eller LS; Lev EL; Gejerman G; Colella J; Esposito M; Lanteri V; Scheuch J; Munver R; Lane P; Junchaya C; Alves L; Galli B; Watson R; Sawczuk I
Nurs Res; 2006; 55(2 Suppl):S28-36. PubMed ID: 16601630
[TBL] [Abstract][Full Text] [Related]
37. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
Bacon CG; Giovannucci E; Testa M; Kawachi I
J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
[TBL] [Abstract][Full Text] [Related]
38. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
Zincke H; Lau W; Bergstralh E; Blute ML
J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
[TBL] [Abstract][Full Text] [Related]
39. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.
Lippert MC; McClain R; Boyd JC; Theodorescu D
Cancer; 1999 Dec; 86(12):2642-8. PubMed ID: 10594859
[TBL] [Abstract][Full Text] [Related]
40. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
